Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Street cleaners in New York have help from insect garbage-munchers

UPI December 2, 2014

Foundation Medicine Appoints David J. Daly as Chief Commercial Officer

Business Wire December 2, 2014

The Linux Foundation Announces 2015 Events Schedule

Marketwired December 2, 2014

Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent and Systemic Anti-Tumor Activity in Preclinical Models

GlobeNewswire December 2, 2014

56th ASH Annual Meeting to Highlight Cutting-Edge Research, Celebrate Major Milestones in Hematology

PR Newswire December 2, 2014

Puma Biotechnology Updates Timeline for Filing New Drug Application

Business Wire December 2, 2014

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis

GlobeNewswire December 2, 2014

Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy

PR Newswire December 2, 2014

Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting

PR Newswire December 2, 2014

Nova Southeastern University Celebrates its 50th Anniversary Year in 2014

PR Newswire December 2, 2014

Research and Markets: United Kingdom Wound Care Management Procedures Outlook to 2020

Business Wire December 2, 2014

Research and Markets: Global Synthetic Biology Market 2014-2018: Market to Reach $5.6 Billion in 2018, Growing at a CAGR of 24%

Business Wire December 2, 2014

Core Informatics Recognized in AWS Partner Network Life Sciences Competency

PR Newswire December 2, 2014

Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration

GlobeNewswire December 2, 2014

STW Water Executes Teaming Agreement With Thermal Energy Partners To Practice Totally Blue/Green Water And Electricity Generation

PR Newswire December 2, 2014

Nordic Nanovector To Present Clinical Data from Phase I/II Trial on Betalutin(TM) at Upcoming American Society of Hematology (ASH) Meeting

Business Wire December 2, 2014

IDT And Ubiquitome Partner To Develop Mobile Ebola Test

PR Newswire December 2, 2014

Aeolus Pharmateucticals to Present at LD Micro Invitational Conference

Marketwired December 2, 2014

RxTrials and Clinical Oncology Research Excellence (CORE) announce a strategic collaboration to launch a cancer specific Investigative Site Network (ISN)

PR Newswire December 2, 2014

ADEAGies Foundation Announces 2015 William J. Gies Awardees for Vision, Innovation and Achievement in Oral Health

Business Wire December 2, 2014